FDA Approved: CYSVIEW — Supplemental Application (Photocure Inc.)

View source ↗

Summary

The FDA has approved a supplemental application for CYSVIEW (HEXAMINOLEVULINATE HYDROCHLORIDE) from Photocure Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Cysview (hexaminolevulinate hydrochloride)

Snippet

SUPPL AP for CYSVIEW (HEXAMINOLEVULINATE HYDROCHLORIDE)